{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T02:10:59Z","timestamp":1776564659587,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceuticals Company of Johnson & Johnson"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s41030-022-00213-9","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T13:11:05Z","timestamp":1673269865000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Why Living with Pulmonary Arterial Hypertension Requires a Holistic Approach: A Patient and Clinician Perspective"],"prefix":"10.1007","volume":"9","author":[{"given":"Haley","family":"Lynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-0871","authenticated-orcid":false,"given":"Melisa","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"key":"213_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/2374373517699267","volume":"4","author":"H Riess","year":"2017","unstructured":"Riess H. The science of empathy. J Patient Exp. 2017;4:74\u20137.","journal-title":"J Patient Exp"},{"key":"213_CR2","unstructured":"Leadership Health Council (LHC) Lunch and Learn, November 2018 LHC members hear physician perspective from Dr. Karl Vandevender: https:\/\/healthcarecouncil.com\/lhc-members-hear-physician-perspective-from-dr-karl-vandevender\/. Accessed Aug 8, 2022."},{"key":"213_CR3","first-page":"565","volume":"13","author":"B Mendel","year":"2021","unstructured":"Mendel B, Angellia P, Ferdinand E, Holiyono HI, Siagian SN, Prakoso R. Pulse oximetry as a screening tool for detecting congenital heart disease: a systematic review and meta-analysis. World Heart J. 2021;13:565\u201375.","journal-title":"World Heart J"},{"issue":"1","key":"213_CR4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1650","volume":"146","author":"GR Martin","year":"2020","unstructured":"Martin GR, Ewer AK, Gaviglio A, et al. Updated strategies for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2020;146(1):e20191650.","journal-title":"Pediatrics"},{"key":"213_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","volume":"38","author":"G Hansmann","year":"2019","unstructured":"Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38:879\u2013901.","journal-title":"J Heart Lung Transplant"},{"key":"213_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/PEC.0000000000000331","volume":"31","author":"JW Elder","year":"2015","unstructured":"Elder JW, Baraff SB, Gaschler WN, Baraff LJ. Pulse oxygen saturation values in a healthy school-aged population. Pediatr Emerg Care. 2015;31:645\u20137.","journal-title":"Pediatr Emerg Care"},{"issue":"25","key":"213_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011135","volume":"97","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Fukuda S, Takano KI, Kamizono J, Ichikawa K. Can a pulse oxygen saturation of 95% to 96% help predict further vital sign destabilization in school-aged children? A retrospective observational study. Medicine. 2018;97(25):e11135.","journal-title":"Medicine"},{"issue":"2","key":"213_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4187\/respcare.09795","volume":"67","author":"OE Okunlola","year":"2022","unstructured":"Okunlola OE, Lipnick MS, Batchelder PB, Bernstein M, Feiner JR, Bickler PE. Pulse oximeter performance, racial inequity, and the work ahead. Respir Care. 2022;67(2):252\u20137.","journal-title":"Respir Care"},{"key":"213_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-022-02452-8","volume":"20","author":"C Shi","year":"2022","unstructured":"Shi C, Goodall M, Dumville J, et al. The accuracy of pulse oximetry in measuring oxygen saturation by levels of skin pigmentation: a systematic review and meta-analysis. BMC Med. 2022;20:1\u20134.","journal-title":"BMC Med"},{"key":"213_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/1054773812446510","volume":"21","author":"JS Everett","year":"2012","unstructured":"Everett JS, Budescu M, Sommers MS. Making sense of skin color in clinical care. Clin Nurs Res. 2012;21:495\u2013516.","journal-title":"Clin Nurs Res"},{"key":"213_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001150","volume":"7","author":"M Lee","year":"2020","unstructured":"Lee M, Oh JH. Echocardiographic diagnosis of right-to-left shunt using transoesophageal and transthoracic echocardiography. Open Heart. 2020;7:e001150.","journal-title":"Open Heart"},{"key":"213_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0050-2019","volume":"28","author":"K Swinnen","year":"2019","unstructured":"Swinnen K, Quarck R, Godinas L, Belge C, Delcroix M. Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations. Eur Respir Rev. 2019;28:190050. https:\/\/doi.org\/10.1183\/16000617.0050-2019.","journal-title":"Eur Respir Rev"},{"key":"213_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40949-020-00032-0","volume":"4","author":"R Condliffe","year":"2020","unstructured":"Condliffe R. Pulmonary arterial hypertension associated with congenital heart disease: classification and pathophysiology. J Congenit Cardiol. 2020;4:1\u20137.","journal-title":"J Congenit Cardiol"},{"issue":"6","key":"213_CR14","doi-asserted-by":"publisher","first-page":"00299","DOI":"10.1183\/23120541.00299-2020","volume":"1","author":"B Kjellstr\u00f6m","year":"2020","unstructured":"Kjellstr\u00f6m B, Sandqvist A, Hjalmarsson C, Nisell M, N\u00e4sman P, Ivarsson B. Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. ERJ Open Res. 2020;1(6):00299\u20132020. https:\/\/doi.org\/10.1183\/23120541.00299-2020.","journal-title":"ERJ Open Res"},{"key":"213_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3111\/13696998.2012.756399","volume":"16","author":"A Waxman","year":"2013","unstructured":"Waxman A, Chen SY, Boulanger L, Watson JA, Golden G. Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension. J Med Econ. 2013;16:298\u2013306.","journal-title":"J Med Econ"},{"key":"213_CR16","doi-asserted-by":"publisher","first-page":"045894019880086","DOI":"10.1177\/2045894019880086","volume":"10","author":"RP Frantz","year":"2020","unstructured":"Frantz RP, Hill JW, Lickert CA, et al. Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors. Pulm Circ. 2020;10:045894019880086. https:\/\/doi.org\/10.1177\/2045894019880086.","journal-title":"Pulm Circ"},{"key":"213_CR17","doi-asserted-by":"publisher","first-page":"204589321774361","DOI":"10.1177\/2045893217743616","volume":"8","author":"D Grady","year":"2017","unstructured":"Grady D, Weiss M, Hernandez-Sanchez J, Pepke-Zaba J. Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies. Pulm Circ. 2017;8:2045893217743616. https:\/\/doi.org\/10.1177\/2045893217743616.","journal-title":"Pulm Circ"},{"key":"213_CR18","doi-asserted-by":"publisher","first-page":"A620","DOI":"10.1016\/j.jval.2017.08.1347","volume":"20","author":"JW Hill","year":"2017","unstructured":"Hill JW, Lickert CB, Cole MR, Wade RL, Tsang Y, Drake W. Medication adherence and risk of hospitalization in pulmonary arterial hypertension (PAH) patients treated with endothelin receptor antagonists (ERAS) or phosphodiesterase type 5 inhibitors (PDE5IS). Value Health. 2017;20:A620.","journal-title":"Value Health"},{"key":"213_CR19","first-page":"157","volume":"53","author":"M Troy","year":"2019","unstructured":"Troy M. Facilitating and improving adherence: the development of a pulmonary arterial hypertension self-care management agreement. Adv Pulm Hypertens. 2019;53:157\u201362.","journal-title":"Adv Pulm Hypertens"},{"key":"213_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.21693\/1933-088X-18.4.157","volume":"18","author":"JM Brewer","year":"2019","unstructured":"Brewer JM, Allen SA. PH Professional Network: facilitating and improving adherence: the development of a pulmonary arterial hypertension self-care management agreement. Adv Pulm Hypertens. 2019;18:157\u20139.","journal-title":"Adv Pulm Hypertens"},{"issue":"14","key":"213_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217798","volume":"6","author":"NB Shah","year":"2019","unstructured":"Shah NB, Mitchell RE, Proctor ST, et al. High rates of medication adherence in patients with pulmonary arterial hypertension: an integrated specialty pharmacy approach. PLoS\u00a0One. 2019;14:e0217798.","journal-title":"PLoS One"},{"key":"213_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1183\/16000617.0078-2016","volume":"25","author":"J Graarup","year":"2016","unstructured":"Graarup J, Ferrari P, Howard LS. Patient engagement and self-management in pulmonary arterial hypertension. Eur Respir Rev. 2016;25:399\u2013407.","journal-title":"Eur Respir Rev"},{"key":"213_CR23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.pec.2016.12.021","volume":"100","author":"B Ivarsson","year":"2017","unstructured":"Ivarsson B, R\u00e5degran G, Hesselstrand R, Kjellstr\u00f6m B. Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension\u2014a nationwide population-based study. Patient Educ Couns. 2017;100:936\u201342.","journal-title":"Patient Educ Couns"},{"key":"213_CR24","doi-asserted-by":"publisher","first-page":"A2243","DOI":"10.1016\/j.chest.2021.07.1975","volume":"160","author":"M Harris","year":"2021","unstructured":"Harris M, Hanley K, O\u2019Connor AL, Chang LF, Hatcher V, Capparelli C. Success of online CME at improving competence and confidence related to treatment adherence in PAH. Chest. 2021;160:A2243.","journal-title":"Chest"},{"key":"213_CR25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/jim-2021-002027","volume":"69","author":"H Deshwal","year":"2021","unstructured":"Deshwal H, Weinstein T, Sulica R. Advances in the management of pulmonary arterial hypertension. J Investig Med. 2021;69:1270\u201380.","journal-title":"J Investig Med"},{"key":"213_CR26","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"30","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2022;30:2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022.","journal-title":"Eur Respir J"},{"key":"213_CR27","doi-asserted-by":"publisher","first-page":"2102311","DOI":"10.1183\/13993003.02311-2021","volume":"60","author":"M Hoeper","year":"2022","unstructured":"Hoeper M, Pausch C, Olsson K, et al. COMPERA 2.0: a refined 4-strata risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022;60:2102311.","journal-title":"Eur Respir J"},{"key":"213_CR28","doi-asserted-by":"publisher","first-page":"2102419","DOI":"10.1183\/13993003.02419-2021","volume":"59","author":"A Boucly","year":"2022","unstructured":"Boucly A, Weatherald J, Savale L, et al. External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension registry. Eur Respir J. 2022;59:2102419.","journal-title":"Eur Respir J"},{"key":"213_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1183\/09059180.00005713","volume":"22","author":"L Guillevin","year":"2013","unstructured":"Guillevin L, Armstrong I, Aldrighetti R, et al. Understanding the impact of pulmonary arterial hypertension on patients\u2019 and carers\u2019 lives. Eur Respir Rev. 2013;22:535\u201342.","journal-title":"Eur Respir Rev"},{"key":"213_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1183\/16000617.0063-2015","volume":"24","author":"M Delcroix","year":"2015","unstructured":"Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev. 2015;24:621\u20139.","journal-title":"Eur Respir Rev"},{"key":"213_CR31","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.lpm.2015.06.017","volume":"45","author":"S Alami","year":"2016","unstructured":"Alami S, Cottin V, Mouthon L, et al. Patients\u2019, relatives\u2019, and practitioners\u2019 views of pulmonary arterial hypertension: a qualitative study. La Presse M\u00e9dicale. 2016;45:e11-27.","journal-title":"La Presse M\u00e9dicale"},{"key":"213_CR32","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.chest.2018.04.027","volume":"154","author":"KM Chin","year":"2018","unstructured":"Chin KM, Gomberg-Maitland M, Channick RN, et al. Psychometric validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire: results of the SYMPHONY trial. Chest. 2018;154:848\u201361.","journal-title":"Chest"},{"key":"213_CR33","doi-asserted-by":"publisher","first-page":"204589402110132","DOI":"10.1177\/20458940211013258","volume":"11","author":"PC Giri","year":"2021","unstructured":"Giri PC, Stevens GJ, Merrill-Henry J, Oyoyo U, Balasubramanian VP. Participation in pulmonary hypertension support group improves patient-reported health quality outcomes: a patient and caregiver survey. Pulm Circ. 2021;11:20458940211013258. https:\/\/doi.org\/10.1177\/20458940211013258.","journal-title":"Pulm Circ"},{"key":"213_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062564","volume":"12","author":"GH Rawlings","year":"2022","unstructured":"Rawlings GH, Thompson AR, Armstrong I, Novakova B, Beail N. Coping styles associated with depression, health anxiety and health-related quality of life in pulmonary hypertension: cross-sectional analysis. BMJ Open. 2022;12:e062564.","journal-title":"BMJ Open"},{"key":"213_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.667602","volume":"12","author":"KM Olsson","year":"2021","unstructured":"Olsson KM, Meltendorf T, Fuge J, et al. Prevalence of mental disorders and impact on quality of life in patients with pulmonary arterial hypertension. Front Psychiatry. 2021;12:667602. https:\/\/doi.org\/10.3389\/fpsyt.2021.667602.","journal-title":"Front Psychiatry"},{"key":"213_CR36","first-page":"3124","volume":"19","author":"X Zhou","year":"2020","unstructured":"Zhou X, Shi H, Yang Y, Zhang Z, Zhai Z, Wang C. Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: results from a Chinese survey. Exp Ther Med. 2020;19:3124\u201332.","journal-title":"Exp Ther Med"},{"key":"213_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.758120","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yin Y, Wen Y, Shi F, Wang J. Anxiety and depression in patients with pulmonary arterial hypertension in Northwest China: a cross-sectional study. Front Psychiatry. 2022;12:758120. https:\/\/doi.org\/10.3389\/fpsyt.2021.758120.","journal-title":"Front Psychiatry"},{"key":"213_CR38","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0069-2018","volume":"27","author":"G Khirfan","year":"2018","unstructured":"Khirfan G, Tonelli AR, Ramsey J, Sahay S. Palliative care in pulmonary arterial hypertension: an underutilised treatment. Eur Respir Rev. 2018;27:180069. https:\/\/doi.org\/10.1183\/16000617.0069-2018.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"213_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s41030-017-0039-1","volume":"3","author":"T Stewart","year":"2017","unstructured":"Stewart T, Burks M, Nolley SH, Hill W, Housten T, Kennedy K, Traiger G. Collaborative care: a defining characteristic for a pulmonary hypertension center. Pulm Ther. 2017;3(1):93\u2013111.","journal-title":"Pulm Ther"},{"key":"213_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1513\/AnnalsATS.202005-552RL","volume":"18","author":"M Hrustanovic-Kadic","year":"2021","unstructured":"Hrustanovic-Kadic M, Ziegler C, El-Kersh K. Palliative care perception in pulmonary arterial hypertension: evaluating the interaction of PPCI, PAH-SYMPACT Questionnaire, and the REVEAL 2.0 risk score. Ann Am Thorac Soc. 2021;18:361\u20134.","journal-title":"Ann Am Thorac Soc"},{"key":"213_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12003","volume":"12","author":"M Wilson","year":"2022","unstructured":"Wilson M, Anguiano RH, Awdish RL, et al. An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension. Pulm Circ. 2022;12:e12003.","journal-title":"Pulm Circ"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-022-00213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-022-00213-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-022-00213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T15:54:22Z","timestamp":1676476462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-022-00213-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s41030-022-00213-9","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}